scorecardresearch
Friday, May 3, 2024
TopicDrug

Topic: Drug

Swarms of bugs, missing data plague firms now making heart drug in India

Inspection reports by US federal agency FDA stated that workers destroyed records indicating that drugs were failing key quality measures.

High time India, the land of bhang, legalises marijuana

Regulation allows cannabis buyers to know what they’re consuming and moderate their intake, in the same way that a drinker can distinguish and choose between a whiskey and a beer.

Pfizer’s Viagra patent set to end in the US, Indian pharma firms sense huge opportunity

Seven get FDA approval to produce the drug, could send prices crashing in the US by nearly 99%.

On Camera

Stop targetting Galgotias University students. Focus on politicians instead

Going through their Instagrams and dissecting their ‘statements’ is not the astute political commentary you think it is—it is time for us to back off from targetting 20-year-olds.

High capacity usage, fresh borrowings & new orders — why FY25 could be a big year for pvt investment

Companies are borrowing more from banks and public. Economists say high capacity utilisation & growing new orders could set stage for renewed investment push by India Inc.

China builds road through Shaksgam Valley, India registers protest

New Delhi has, in past, too, objected to Chinese construction activities in Shaksgam Valley. Work in this strategic region gathered pace after the 2017 Doklam stand-off.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.